Nianmin Shi

563 total citations
12 papers, 128 citations indexed

About

Nianmin Shi is a scholar working on Epidemiology, Virology and Infectious Diseases. According to data from OpenAlex, Nianmin Shi has authored 12 papers receiving a total of 128 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 4 papers in Virology and 3 papers in Infectious Diseases. Recurrent topics in Nianmin Shi's work include Influenza Virus Research Studies (4 papers), Rabies epidemiology and control (4 papers) and Respiratory viral infections research (3 papers). Nianmin Shi is often cited by papers focused on Influenza Virus Research Studies (4 papers), Rabies epidemiology and control (4 papers) and Respiratory viral infections research (3 papers). Nianmin Shi collaborates with scholars based in China, France and South Korea. Nianmin Shi's co-authors include Yunhua Bai, Fengji Luo, Qunying Mao, Junnan Zhang, Kai Chu, Yuntao Zhang, Mingwei Wei, Fanyue Meng, Yuemei Hu and Pei Liu and has published in prestigious journals such as The Journal of Infectious Diseases, Vaccine and Human Vaccines & Immunotherapeutics.

In The Last Decade

Nianmin Shi

12 papers receiving 126 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nianmin Shi China 7 61 55 54 28 26 12 128
Kathrin Keeren Germany 8 57 0.9× 101 1.8× 30 0.6× 7 0.3× 46 1.8× 12 172
Isabel López-Miragaya Spain 6 99 1.6× 45 0.8× 84 1.6× 58 2.1× 5 0.2× 8 176
Mirleide Cordeiro dos Santos Brazil 5 108 1.8× 69 1.3× 12 0.2× 10 0.4× 5 0.2× 15 158
Zhihong Deng China 7 80 1.3× 70 1.3× 37 0.7× 86 3.1× 2 0.1× 12 147
Pedro Pechirra Portugal 7 126 2.1× 43 0.8× 6 0.1× 15 0.5× 6 0.2× 23 160
Rebecca Lampley United States 4 105 1.7× 38 0.7× 9 0.2× 9 0.3× 24 0.9× 5 170
Azwidowi Lukhwareni South Africa 7 289 4.7× 122 2.2× 31 0.6× 34 1.2× 53 2.0× 11 364
Arianna Rocca Italy 6 35 0.6× 31 0.6× 5 0.1× 7 0.3× 12 0.5× 10 142
Cynthia Yen United States 6 80 1.3× 73 1.3× 66 1.2× 7 0.3× 9 160
Kathleen Gibson United States 3 42 0.7× 64 1.2× 5 0.1× 5 0.2× 13 0.5× 3 155

Countries citing papers authored by Nianmin Shi

Since Specialization
Citations

This map shows the geographic impact of Nianmin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nianmin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nianmin Shi more than expected).

Fields of papers citing papers by Nianmin Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nianmin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nianmin Shi. The network helps show where Nianmin Shi may publish in the future.

Co-authorship network of co-authors of Nianmin Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Nianmin Shi. A scholar is included among the top collaborators of Nianmin Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nianmin Shi. Nianmin Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Lv, Huakun, Jikai Zhang, Na Xu, et al.. (2024). Immunogenicity and safety of live attenuated influenza vaccine in children aged 3–17 years in China. Vaccine. 46. 126653–126653. 2 indexed citations
2.
3.
Zhang, Junnan, Nianmin Shi, Guohua Li, et al.. (2022). Population Pharmacodynamic Analyses of Human Anti-Rabies Virus Monoclonal Antibody (Ormutivimab) in Healthy Adult Subjects. Vaccines. 10(8). 1218–1218. 4 indexed citations
4.
5.
Wang, Jing, Fengji Luo, Zijian Feng, et al.. (2017). Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above. Human Vaccines & Immunotherapeutics. 13(1). 144–150. 8 indexed citations
6.
Shi, Nianmin, Yibin Zhang, Huizhen Zheng, et al.. (2017). Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects. Human Vaccines & Immunotherapeutics. 13(6). 1338–1345. 19 indexed citations
7.
Shi, Nianmin, Qiang Lu, Jianyu Zhang, et al.. (2017). Analysis of risk factors for persistent infection of asymptomatic women with high-risk human papilloma virus. Human Vaccines & Immunotherapeutics. 13(6). 1404–1411. 13 indexed citations
8.
Wei, Mingwei, Fanyue Meng, Shiyuan Wang, et al.. (2016). 2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study. The Journal of Infectious Diseases. 215(1). 56–63. 51 indexed citations
9.
Bai, Yunhua, Nianmin Shi, Zhaoyun Wang, et al.. (2015). Immunological persistence of a seasonal influenza vaccine in people more than 3 years old. Human Vaccines & Immunotherapeutics. 11(7). 1648–1653. 4 indexed citations
10.
Luo, Fengji, Xing Ai, Yunhua Bai, et al.. (2013). Immunogenicity and safety of three 2010–2011 seasonal trivalent influenza vaccines in Chinese toddlers, children and older adults. Human Vaccines & Immunotherapeutics. 9(8). 1725–1734. 8 indexed citations
11.
Shi, Nianmin, Fengji Luo, Li Li, et al.. (2013). A randomized, controlled, blinded study of the safety and immunogenicity ofHaemophilus influenzaetype b conjugate vaccine injected at different intramuscular sites in Chinese infants. Human Vaccines & Immunotherapeutics. 9(11). 2311–2315. 2 indexed citations
12.
Li, Shu‐Ming, Li Li, Xing Ai, et al.. (2013). A randomized, controlled, blinded study of the safety, immunogenicity and batch consistency of Aleph inactivated split influenza vaccine made in China in Chinese people. Human Vaccines & Immunotherapeutics. 10(3). 557–565. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathrin Keeren Breakdown of academic impact, for papers by Isabel López-Miragaya Breakdown of academic impact, for papers by Mirleide Cordeiro dos Santos Breakdown of academic impact, for papers by Zhihong Deng Breakdown of academic impact, for papers by Pedro Pechirra Breakdown of academic impact, for papers by Rebecca Lampley Breakdown of academic impact, for papers by Azwidowi Lukhwareni Breakdown of academic impact, for papers by Arianna Rocca Breakdown of academic impact, for papers by Cynthia Yen Breakdown of academic impact, for papers by Kathleen Gibson
Rankless by CCL
2026